NEW YORK (GenomeWeb News) — GE Healthcare today said Applied Biosystems has licensed its patents covering biomagnetic isolation of nucleic acids.
Under the agreement, ABI has access to the magnetic separation IP to isolate and purify nucleic acids through the duration of the patents, GE Healthcare said.
This technology is used with DNA and RNA from lab and clinical samples, and GE Healthcare said it offers higher yields and does not clog, which the company said is a drawback to filter-based isolation methods.
GE Healthcare said ABI plans to use the separation protocol with its MagMax isolation kits.
Financial terms of the agreement were not disclosed.